140 related articles for article (PubMed ID: 31933583)
1. Breast Cancer: Reimbursement Policies and Adoption of New Therapeutic Agents by National Health Systems.
Trapani D; Curigliano G; Eniu A
Breast Care (Basel); 2019 Dec; 14(6):373-381. PubMed ID: 31933583
[TBL] [Abstract][Full Text] [Related]
2. The global landscape of availability, accessibility and affordability of essential diagnostics and therapeutics for the management of HER2-positive breast cancer: The ONCOLLEGE-001 survey.
Trapani D; Lengyel CG; Habeeb BS; Altuna SC; Petrillo A; El Bairi K; Hussain S; Mazher SA; Elfaham EM; Curigliano G; Khan SZ
J Cancer Policy; 2021 Jun; 28():100285. PubMed ID: 35559914
[TBL] [Abstract][Full Text] [Related]
3. A review of promoting access to medicines in China - problems and recommendations.
Sun J; Hu CJ; Stuntz M; Hogerzeil H; Liu Y
BMC Health Serv Res; 2018 Feb; 18(1):125. PubMed ID: 29458428
[TBL] [Abstract][Full Text] [Related]
4. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
Newell S; Jordan Z
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
[TBL] [Abstract][Full Text] [Related]
5. Association of Out-of-Pocket Annual Health Expenditures With Financial Hardship in Low-Income Adults With Atherosclerotic Cardiovascular Disease in the United States.
Khera R; Valero-Elizondo J; Okunrintemi V; Saxena A; Das SR; de Lemos JA; Krumholz HM; Nasir K
JAMA Cardiol; 2018 Aug; 3(8):729-738. PubMed ID: 29971325
[TBL] [Abstract][Full Text] [Related]
6. Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.
Kandolf Sekulovic L; Guo J; Agarwala S; Hauschild A; McArthur G; Cinat G; Wainstein A; Caglevic C; Lorigan P; Gogas H; Alvarez M; Duncombe R; Lebbe C; Peris K; Rutkowski P; Stratigos A; Forsea AM; De La Cruz Merino L; Kukushkina M; Dummer R; Hoeller C; Gorry C; Bastholt L; Herceg D; Neyns B; Vieira R; Arenberger P; Bylaite-Bucinskiene M; Babovic N; Banjin M; Putnik K; Todorovic V; Kirov K; Ocvirk J; Zhukavets A; Ymeri A; Stojkovski I; Garbe C
Eur J Cancer; 2018 Nov; 104():201-209. PubMed ID: 30388700
[TBL] [Abstract][Full Text] [Related]
7. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.
Vogler S; Paris V; Ferrario A; Wirtz VJ; de Joncheere K; Schneider P; Pedersen HB; Dedet G; Babar ZU
Appl Health Econ Health Policy; 2017 Jun; 15(3):307-321. PubMed ID: 28063134
[TBL] [Abstract][Full Text] [Related]
8. Remote monitoring costs, benefits, and reimbursement: a European perspective.
Chronaki CE; Vardas P
Europace; 2013 Jun; 15 Suppl 1():i59-i64. PubMed ID: 23737233
[TBL] [Abstract][Full Text] [Related]
9. Heart failure: preventing disease and death worldwide.
Ponikowski P; Anker SD; AlHabib KF; Cowie MR; Force TL; Hu S; Jaarsma T; Krum H; Rastogi V; Rohde LE; Samal UC; Shimokawa H; Budi Siswanto B; Sliwa K; Filippatos G
ESC Heart Fail; 2014 Sep; 1(1):4-25. PubMed ID: 28834669
[TBL] [Abstract][Full Text] [Related]
10. [Risk sharing methods in middle income countries].
Inotai A; Kaló Z
Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
[TBL] [Abstract][Full Text] [Related]
11. The impact of i-PUSH on maternal and child health care utilization, health outcomes, and financial protection: study protocol for a cluster randomized controlled trial based on financial and health diaries data.
Abajobir A; de Groot R; Wainaina C; Njeri A; Maina D; Njoki S; Mbaya N; Donfouet HPP; Pradhan M; Janssens W; Sidze EM
Trials; 2021 Sep; 22(1):629. PubMed ID: 34526072
[TBL] [Abstract][Full Text] [Related]
12. Policy and priorities for national cancer control planning in low- and middle-income countries: Lessons from the Association of Southeast Asian Nations (ASEAN) Costs in Oncology prospective cohort study.
ACTION Study Group
Eur J Cancer; 2017 Mar; 74():26-37. PubMed ID: 28335885
[TBL] [Abstract][Full Text] [Related]
13. Understanding the Financial Needs Following Diagnosis of Breast Cancer in a Setting with Universal Health Coverage.
Kong YC; Wong LP; Ng CW; Taib NA; Bhoo-Pathy NT; Yusof MM; Aziz AF; Yehgambaram P; Ishak WZW; Yip CH; Bhoo-Pathy N
Oncologist; 2020 Jun; 25(6):497-504. PubMed ID: 31922332
[TBL] [Abstract][Full Text] [Related]
14. Value added medicines: what value repurposed medicines might bring to society?
Toumi M; Rémuzat C
J Mark Access Health Policy; 2017; 5(1):1264717. PubMed ID: 28265347
[No Abstract] [Full Text] [Related]
15. Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?
Eniu A; Cherny NI; Bertram M; Thongprasert S; Douillard JY; Bricalli G; Vyas M; Trapani D
ESMO Open; 2019; 4(4):e000483. PubMed ID: 31423334
[TBL] [Abstract][Full Text] [Related]
16. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
